Patent · US Active

Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders

US8969377B2 · kind B2 · utility

2Cited by
5References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2013
Grant dateMar 3, 2015
Priority date
Expiry dateMar 14, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to compounds of the structure (X):wherein: wherein: wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.